InSys Investor Suit Put On Hold As Criminal Action Plays Out
A derivative suit brought against the directors and officers of drugmaker Insys Therapeutics Inc. in Delaware Chancery Court over an alleged off-label prescription scheme will be stayed as federal criminal proceedings...To view the full article, register now.
Already a subscriber? Click here to view full article